Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Exploring Ugi-Azide Four-Component Reaction Products for Broad-Spectrum Influenza Antivirals with a High Genetic Barrier to Drug Resistance
Jiantao Zhang, Yanmei Hu, Christopher Foley, et al.
Scientific Reports (2018) Vol. 8, Iss. 1
Open Access | Times Cited: 30

Showing 1-25 of 30 citing articles:

Thein vitroantiviral activity of lactoferrin against common human coronaviruses and SARS-CoV-2 is mediated by targeting the heparan sulfate co-receptor
Yanmei Hu, Xiangzhi Meng, Fushun Zhang, et al.
Emerging Microbes & Infections (2021) Vol. 10, Iss. 1, pp. 317-330
Open Access | Times Cited: 165
Expedited Approach toward the Rational Design of Noncovalent SARS-CoV-2 Main Protease Inhibitors
Naoya Kitamura, M. Sacco, Chunlong Ma, et al.
Journal of Medicinal Chemistry (2021) Vol. 65, Iss. 4, pp. 2848-2865
Open Access | Times Cited: 135
Boceprevir, Calpain Inhibitors II and XII, and GC-376 Have Broad-Spectrum Antiviral Activity against Coronaviruses
Yanmei Hu, Chunlong Ma, Tommy Szeto, et al.
ACS Infectious Diseases (2021) Vol. 7, Iss. 3, pp. 586-597
Open Access | Times Cited: 95
Novel magnetic propylsulfonic acid-anchored isocyanurate-based periodic mesoporous organosilica (Iron oxide@PMO-ICS-PrSO3H) as a highly efficient and reusable nanoreactor for the sustainable synthesis of imidazopyrimidine derivatives
Arezoo Akbari, Mohammad G. Dekamin, Amene Yaghoubi, et al.
Scientific Reports (2020) Vol. 10, Iss. 1
Open Access | Times Cited: 40
Antiviral strategies against influenza virus: an update on approved and innovative therapeutic approaches
Anna Bonomini, Beatrice Mercorelli, Arianna Loregian
Cellular and Molecular Life Sciences (2025) Vol. 82, Iss. 1
Open Access
Novel antiviral drug discovery strategies to tackle drug-resistant mutants of influenza virus strains
Woo-Jin Shin, Baik Lin Seong
Expert Opinion on Drug Discovery (2018) Vol. 14, Iss. 2, pp. 153-168
Closed Access | Times Cited: 42
Inhibition of Influenza Virus Polymerase by Interfering with Its Protein–Protein Interactions
Serena Massari, Jenny Desantis, Maria Giulia Nizi, et al.
ACS Infectious Diseases (2020) Vol. 7, Iss. 6, pp. 1332-1350
Open Access | Times Cited: 29
Optimization of potent, broad-spectrum, and specific anti-influenza compounds targeting RNA polymerase PA-PB1 heterodimerization
Anna Bonomini, Tommaso Felicetti, Martina Pacetti, et al.
European Journal of Medicinal Chemistry (2024) Vol. 277, pp. 116737-116737
Closed Access | Times Cited: 3
A Novel Capsid Binding Inhibitor Displays Potent Antiviral Activity against Enterovirus D68
Chunlong Ma, Yanmei Hu, Jiantao Zhang, et al.
ACS Infectious Diseases (2019) Vol. 5, Iss. 11, pp. 1952-1962
Open Access | Times Cited: 26
Discovery of Influenza Polymerase PA–PB1 Interaction Inhibitors Using an In Vitro Split-Luciferase Complementation-Based Assay
Jiantao Zhang, Yanmei Hu, Nan Wu, et al.
ACS Chemical Biology (2019) Vol. 15, Iss. 1, pp. 74-82
Open Access | Times Cited: 26
Potent and broad-spectrum cycloheptathiophene-3-carboxamide compounds that target the PA-PB1 interaction of influenza virus RNA polymerase and possess a high barrier to drug resistance
Giulio Nannetti, Serena Massari, Beatrice Mercorelli, et al.
Antiviral Research (2019) Vol. 165, pp. 55-64
Open Access | Times Cited: 25
Contemporary medicinal chemistry strategies for the discovery and optimization of influenza inhibitors targeting vRNP constituent proteins
Lingxin Hou, Ying Zhang, Han Ju, et al.
Acta Pharmaceutica Sinica B (2021) Vol. 12, Iss. 4, pp. 1805-1824
Open Access | Times Cited: 19
Small-Molecule Inhibitor of Flaviviral NS3-NS5 Interaction with Broad-Spectrum Activity and Efficacy In Vivo
Marta Celegato, Mattia Sturlese, Vivian Vasconcelos Costa, et al.
mBio (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 7
Boceprevir, calpain inhibitors II and XII, and GC-376 have broad-spectrum antiviral activity against coronaviruses in cell culture
Yanmei Hu, Chunlong Ma, Tommy Szeto, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2020)
Open Access | Times Cited: 15
Cytopathic Effect Assay and Plaque Assay to Evaluate in vitro Activity of Antiviral Compounds Against Human Coronaviruses 229E, OC43, and NL63
Yanmei Hu, Chunlong Ma, Jun Wang
BIO-PROTOCOL (2022) Vol. 12, Iss. 3
Open Access | Times Cited: 9
Approaches for discovery of small-molecular antivirals targeting to influenza A virus PB2 subunit
Wenteng Chen, Jiaan Shao, Zhimin Ying, et al.
Drug Discovery Today (2022) Vol. 27, Iss. 6, pp. 1545-1553
Open Access | Times Cited: 9
A modulator of the low-voltage-activated T-type calcium channel that reverses HIV glycoprotein 120-, paclitaxel-, and spinal nerve ligation-induced peripheral neuropathies
Song Cai, Peter Tuohy, Chunlong Ma, et al.
Pain (2020) Vol. 161, Iss. 11, pp. 2551-2570
Open Access | Times Cited: 14
Recent trends in the design of antimicrobial agents using Ugi-multicomponent reaction
Mukesh Tandi, Sandeep Sundriyal
Journal of the Indian Chemical Society (2021) Vol. 98, Iss. 8, pp. 100106-100106
Closed Access | Times Cited: 10
Multicomponent Reactions in the Synthesis of Antiviral Compounds
Lorenzo Botta, Silvia Cesarini, Claudio Zippilli, et al.
Current Medicinal Chemistry (2021) Vol. 29, Iss. 12, pp. 2013-2050
Closed Access | Times Cited: 10
Application of Chiral Isocyanides in Multicomponent Reactions
Vaezeh Fathi Vavsari, Pegah Shakeri, Saeed Balalaie
Current Organic Chemistry (2020) Vol. 24, Iss. 2, pp. 162-183
Closed Access | Times Cited: 10
Lead Optimization of Influenza Virus RNA Polymerase Inhibitors Targeting PA–PB1 Interaction
Satoshi Mizuta, Hiroki Otaki, Takeshi Ishikawa, et al.
Journal of Medicinal Chemistry (2021) Vol. 65, Iss. 1, pp. 369-385
Closed Access | Times Cited: 9
Novel influenza inhibitors designed to target PB1 interactions with host importin RanBP5
Gregory Mohl, Nathan Liddle, Joseph M.L. Nygaard, et al.
Antiviral Research (2019) Vol. 164, pp. 81-90
Closed Access | Times Cited: 9
Anti-Influenza Drug Discovery and Development: Targeting the Virus and Its Host by All Possible Means
Olivier Terrier, Anny Slama‐Schwok
Advances in experimental medicine and biology (2021), pp. 195-218
Closed Access | Times Cited: 8
Stereospecific Effects of Benzimidazolonepiperidine Compounds on T-Type Ca2+Channels and Pain
Kimberly Gómez, Cheng Tang, Bin Tan, et al.
ACS Chemical Neuroscience (2022) Vol. 13, Iss. 13, pp. 2035-2047
Closed Access | Times Cited: 5
Three Complementary One‐Pot Four‐Component Reaction Sequences for Rapid, General and Direct Spiropyran Synthesis
Christopher A. Hughes‐Whiffing, Alexis Perry
European Journal of Organic Chemistry (2022) Vol. 26, Iss. 2
Open Access | Times Cited: 5
Page 1 - Next Page

Scroll to top